Systematic review of literature and analysis of big data from the National Health Insurance System on primary immunodeficiencies in Korea |
Son, Sohee
(Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Kang, Ji-Man (Department of Pediatrics, Severance Children's Hospital, Yonsei University College of Medicine) Hahn, Younsoo (Department of Pediatrics, Chungbuk National University Hospital) Ahn, Kangmo (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) Kim, Yae-Jean (Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine) |
1 | Bousfiha A, Jeddane L, Picard C, Ailal F, Bobby Gaspar H, Al-Herz W, et al. The 2017 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol 2018;38:129-43. DOI |
2 | Al-Mousa H, Abouelhoda M, Monies DM, Al-Tassan N, Al-Ghonaium A, Al-Saud B, et al. Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases. J Allergy Clin Immunol 2016;137:1780-7. DOI |
3 | Fischer A, Hacein-Bey Abina S, Touzot F, Cavazzana M. Gene therapy for primary immunodeficiencies. Clin Genet 2015;88:507-15. DOI |
4 | Press release: the nobel prize in physiology or medicine 2018, a new principle for immune therapy: The Nobel Foundation [Internet]. Stockholm (Sweden): The Nobel Foundation; c2020 [cited 2018 Oct 1]. Available from: https://www.nobelprize.org/prizes/medicine/2018/pressrelease/. |
5 | Classification of Disease (ICD) [Internet]. Geneva (Switzerland): World Health Organization; [cited 2019 Oct 10]. Available from: https://www.who.int/classifications/icd/icdonlineversions/en/. |
6 | Meyts I, Bosch B, Bolze A, Boisson B, Itan Y, Belkadi A, et al. Exome and genome sequencing for inborn errors of immunity. J Allergy Clin Immunol 2016;138:957-69. DOI |
7 | Lo B, Zhang K, Lu W, Zheng L, Zhang Q, Kanellopoulou C, et al. Autoimmune disease. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy. Science 2015;349:436-40. DOI |
8 | Casanova JL, Conley ME, Seligman SJ, Abel L, Notarangelo LD. Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies. J Exp Med 2014;211:2137-49. DOI |
9 | Mamcarz E, Zhou S, Lockey T, Abdelsamed H, Cross SJ, Kang G, et al. Lentiviral gene therapy combined with low-dose busulfan in infants with SCID-X1. N Engl J Med 2019;380:1525-34. DOI |
10 | Lee S, Moon JS, Lee CR, Kim HE, Baek SM, Hwang S, et al. Abatacept alleviates severe autoimmune symptoms in a patient carrying a de novo variant in CTLA-4. J Allergy Clin Immunol 2016;137:327-30. DOI |
11 | Egg D, Schwab C, Gabrysch A, Arkwright PD, Cheesman E, Giulino-Roth L, et al. Increased risk for malignancies in 131 affected CTLA4 mutation carriers. Front Immunol 2018;9:2012. DOI |
12 | Yi ES, Choi YB, Lee NH, Lee JW, Sung KW, Koo HH, et al. Allogeneic hematopoietic cell transplantation in patients with primary immunodeficiencies in Korea: eleven-year experience in a single center. J Clin Immunol 2018;38:757-66. DOI |
13 | Lee JH, Sohn WY, Park HY, Hwang SJ, Seo WH, Kim SJ, et al. A clinical study of primary immunodeficiency disease in a single center in seoul from 1996 to 2004. Pediatr Allergy Respir Dis 2005;15:368-80. |
14 | Impact of NIH Research: National Institutes of Health (NIH) [Internet]. Bethesda (MD): National Institutes of Health; [cited 2018 May 1]. Available from: https://www.nih.gov/about-nih/what-we-do/impact-nihresearch/our-society. |
15 | Primary immunodeficiencies (2016-2017) [Internet]. Grantome: c2015; [cited 12019 Oct 10]. Available from: http://grantome.com/search?q=primary+immunodeficiencies. |
16 | About USIDNET: US Immunodeficiency Network (USIDNET) [Internet]. Towson (MD): USIDNET; [cited 2019 Oct 6]. Available from: https://usidnet.org/. |
17 | Survey of patients with primary immunodeficiency in Korea [Internet]. Cheongju (Korea): Korea Centers for Disease Control and Prevention (KCDC); [cited 2007 Sep 5]. Available from: http://www.cdc.go.kr/CDC/notice/CdcKrInfo0201.jsp?menuIds=HOME001-MNU1154-MNU0005-&fid=28&q_type=title&q_value=%EB%A9%B4%EC%97%AD%EA%B2%B0%ED%95%8D&cid=1188&pageNum=1. |
18 | Kim L, Kim JA, Kim S. A guide for the utilization of Health Insurance Review and Assessment Service National Patient Samples. Epidemiol Health 2014;36:e2014008. |
19 | Ju HY, Kang HJ, Hong CR, Lee JW, Kim H, Song SH, et al. Targeted busulfan and fludarabine-based conditioning for bone marrow transplantation in chronic granulomatous disease. Korean J Pediatr 2016;59:S57-9. DOI |
20 | Kim JS, Hwang J, Choi YH, Kim WS, Kim JG. A case of esophageal obstruction complicated in a patient with chronic granulomatous disease: esophageal obstruction in chronic granulomatous disease. Korean J Pediatr Infec Dis 2014;21:53-8. DOI |
21 | Modell V, Knaus M, Modell F, Roifman C, Orange J, Notarangelo LD. Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discovery. Immunol Res 2014;60:132-44. DOI |
22 | Bousfiha AA, Jeddane L, Ailal F, Benhsaien I, Mahlaoui N, Casanova JL, et al. Primary immunodeficiency diseases worldwide: more common than generally thought. J Clin Immunol 2013;33:1-7. |
23 | The United States Immunodeficiency Network (USIDNET) [Internet]. Towson (MD): USIDNET; [cited 2019 June 27]. Available from: www.USIDNET.org. |
24 | Registry Working Party ESID Registry [Internet]. Amsterdam (The Netherlands): European Society for Immunodeficiencies (ESID); [cited 2019 Oct 7]. Available from: https://esid.org/Working-Parties/RegistryWorking-Party/ESID-Registry. |
25 | Ishimura M, Takada H, Doi T, Imai K, Sasahara Y, Kanegane H, et al. Nationwide survey of patients with primary immunodeficiency diseases in Japan. J Clin Immunol 2011;31:968-76. DOI |
26 | Kirkpatrick P, Riminton S. Primary immunodeficiency diseases in Australia and New Zealand. J Clin Immunol 2007;27:517-24. DOI |
27 | Modell V, Orange JS, Quinn J, Modell F. Global report on primary immunodeficiencies: 2018 update from the Jeffrey Modell Centers Network on disease classification, regional trends, treatment modalities, and physician-reported outcomes. Immunol Res 2018;66:367-80. DOI |
28 | The Sixth Revision of the Korean Standard Classification of Diseases: Statistics Korea [Internet]. Daejeon (Korea): Statistics Korea; [cited 2010 Jul 13]. Available from: http://kostat.go.kr/portal/eng/news/3/index.board?bmode=read&aSeq=71706. |
29 | World Population Prospects: United Nations Department of Economic and Social Affairs (UN DESA). New York: United Nations; [cited 2017 June 21]. Available from: https://www.un.org/development/desa/publications/world-population-prospects-the-2017-revision.html. |
30 | Espinosa-Rosales FJ, Condino-Neto A, Franco JL, Sorensen RU. Into action: improving access to optimum care for all primary immunodeficiency patients. J Clin Immunol 2016;36:415-7. DOI |
31 | Rhim JW, Kim KH, Kim DS, Kim BS, Kim JS, Kim CH, et al. Prevalence of primary immunodeficiency in Korea. J Korean Med Sci 2012;27:788-93. DOI |
32 | USIDNET (2016-2017) [Internet]. Grantome: c2015; [cited 2018 Month Day]. Available from: http://grantome.com/search?q=USIDNET. |
![]() |